Top Medical Searches

Current Medical News

New Strides Against Prostate Cancer

Drug companies have scored a string of recent successes against advanced prostate cancer, ending a long drought during which there seemed to be few weapons to combat the disease. Read more…

January 31st, 2012

HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial

Subcutaneous Administration of Conditionally Active RecombinantHuman Cathepsin Was Well Tolerated Download image SAN DIEGO, Jan. 31, 2012 /PRNewswire/ — HalozymeTherapeutics, Inc. (NASDAQ: HALO) today presented interim resultsfrom the…


 Read more…

January 31st, 2012

Pfizer, Lilly Profits Fall as Drugs Lose Patents

Pfizer and Lilly were hurt by the “patent cliff,” with each reporting declines in fourth-quarter profit due to new generic competition for top-selling drugs.  Read more…

January 31st, 2012

Ampio Pharmaceuticals, Inc. Announces Statistically Significant Improvement in Pain Relief for its Lead Product, Ampion(TM) in the Osteoarthritis of the Knee Trial.

GREENWOOD VILLAGE, Colo., Jan. 31, 2012 /PRNewswire/ — AmpioPharmaceuticals, Inc. (NASDAQ: AMPE) (“Ampio” or the “Company”), acompany that discovers and develops new uses for previouslyapproved drugs and new molecular entities (“NMEs”), today…


 Read more…

January 31st, 2012

FDA Approves Cystic Fibrosis Drug

The FDA approved a new medicine treat an underlying cause of cystic fibrosis, a pill that targets a genetic mutation affecting a small minority of patients suffering from the breathing disorder.  Read more…

January 31st, 2012
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us